With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is establishing voluntary licensing agreements and expanded access programs to prepare for the potential launch of a monthly oral HIV prevention pill.
5 independently checked trend briefs about this subject, newest first.
headlinez.news detected 5 source-qualified news clusters connected to Hiv between June 23, 2026 and July 24, 2026. They span 2 newsroom categories and average 6.6 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
Merck is establishing voluntary licensing agreements and expanded access programs to prepare for the potential launch of a monthly oral HIV prevention pill.
A Philadelphia dental clinic has resumed operations following a two-month closure triggered by infection-control concerns and a patient health alert.
Recent advancements in mRNA technology are generating renewed optimism for the development of a viable HIV vaccine.
A new study reports that 1,700 HIV treatment sites have closed globally following funding cuts by the Trump administration.
Activists clash with Congress over proposed $1B HIV funding cuts, calling it a threat to decades of progress